It's crazy thinking, I know, but could these deals
Post# of 148330
He hasn't answered me yet but somehow seemed to think that money would go to Cytodyn (and they could not refuse because they need money).
That of course is nonsense as in the case of a BO the money would go to Cydy shareholders.
Maybe it was not about a BO, but about a partnership/licensing deal based on a combo therapy value of $ 2.32 billion.
Is there some truth in his story?